The Government supports research into common and rare diseases through the Department funded National Institute for Health Research (NIHR) in England. The NIHR welcomes funding applications for research into any aspect of human health, including Trimethylaminuria. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.
The Government also supports research into rare diseases through the Medical Research Council, funded by the Department for Business, Energy and Industrial Strategy.